Share This Page
Details for Patent: 8,066,975
✉ Email this page to a colleague
Summary for Patent: 8,066,975
| Title: | Foaming composition for washing and treating hair and/or scalp based on an active principle | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract: | The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterized in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventor(s): | Isabelle Preuilh, Anne-Emmanuelle Guise, Nathalie Willcox | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Assignee: | Galderma SA | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Application Number: | US11/984,018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Patent Claim Types: see list of patent claims | Use; Composition; | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Patent landscape, scope, and claims: | US Patent 8,066,975: Scope, Claim Construction, and US Patent Landscape for Clobetasol Propionate Stable ShampooWhat does US 8,066,975 claim, in product terms?US 8,066,975 claims a “stable shampoo” for washing and treating hair and/or scalp that is defined by (i) an anti-inflammatory corticosteroid active, (ii) a specific surfactant system built around sodium lauryl ether sulphate (SLES) and cocoyl betaine, (iii) a polymeric conditioning/thickening component, (iv) a high ethanol level, and (v) a tight pH band. Core formula constraints shared across the independent claim setAcross claims 1-3, the composition is locked to these ranges/specs:
What is the claim architecture and how broad is it?Independent claims (1-3)These are formula claims with multiple tiered options. The breadth comes from allowing multiple polymer choices and specifying ranges for surfactants and polymer concentration. The constraining features are the fixed active level (0.05 wt %) and the fixed pH window (5.5 to 6.5), plus the presence of ethanol at a specified level (claims 2-3) and defined ethanol strength. Claim 1 (SLES/cocoyl betaine + polyquaternium 10 + 2 wt% ethanol)
Claim 2 (polyquaternium 10 OR cationic guar gum + 10 wt% ethanol)
Claim 3 (broad polymer range + “cosmetically acceptable basifying or acidifying agents” to pH)
Practical breadth read: Claim 3 is the broadest on pH-control reagents and conditioning polymer concentration. Claims 1-2 are narrower because they tie pH to citric acid/sodium citrate (1-2) and (1-2) fix polymer to 2 wt % (polyquaternium 10) or a specific alternative level (0.5 wt % cationic guar gum in claim 2). Dependent claims (4-6): ratios as “secondary constraints”These tighten the surfactant system internal balance.
What this means for scope: The ratios limit which embodiments in claims 1-3 are captured even if they are otherwise within the component ranges. They function as additional “numerical guardrails” that can be used both to market-proof a competitor and to assess non-infringing design targets. Which elements most likely control infringement risk?In formula claims like these, infringement usually turns on whether a product contains the claimed ingredients at (or within) the claimed amounts, and whether the pH is within the claimed band. Highest-impact limitations (hard constraints)
Medium-impact limitations (help narrow, but can be designed around)
“Stable shampoo” limitation“Stable” is a product property phrase. In practice, it can be used to argue that the claimed combination achieves stability. For infringement, stability is often less determinative than whether the composition literally falls within the numeric ingredient/pH ranges. For validity, it can support a “technical effect” argument tied to the combination. How can a competitor design around these claims (US practice framing)?Even without prosecution history, the numeric structure indicates the main design-around levers: Design-around levers
Ratios (claims 4-6) as targeted carve-outs
Claim chart style mapping (representative embodiment)Below is a mechanical check against claims 1-3 using a hypothetical “in-range” target. This is not a statement about any real product; it shows where a product would land relative to the claim constraints.
The moment any of the hard constraints breaks (active level, pH, SLES/cocoyl betaine ranges, ethanol level, polymer presence), literal infringement risk drops. What is the likely patent landscape around this formulation?A complete landscape requires bibliographic and citation data (family members, citing/cited patents, examiner citations, and prosecution history). Your excerpt provides only claim text and does not provide document metadata (assignee, priority, filing date), nor does it list related patents, INPADOC family members, or forward citations. Under the constraints here, the landscape can only be characterized at a structural level based on what this patent claims: it sits in the intersection of (i) topical corticosteroid (clobetasol propionate) delivery in a shampoo format, (ii) “stable” formulations with specific surfactant systems, and (iii) ethanol and pH-controlled surfactant polymer blends. Landscape inference from claim scope (what to expect around it)The competitive US IP set around this claim typically clusters into three categories:
This patent’s novelty posture, based on the tight numeric combination, is likely the specific stabilization of a clobetasol propionate shampoo using the SLES/cocoyl betaine surfactant system with polymer plus ethanol and a defined pH band. What is the scope of protection compared to claim 1 vs claim 3?Claim 3 likely covers more variations because:
That shifts protection from “exact ingredient set” toward “functional parameter set” (same active level, same surfactants ranges, same ethanol, same pH band, polymer within a broad range). Claims 1-2 are narrower on pH adjusters and on polymer level branches. Key Takeaways
FAQs1) Does the patent require citric acid/sodium citrate?Claims 1-2 (as excerpted) require citric acid and sodium citrate to set pH to 5.5-6.5. Claim 3 instead uses “cosmetically acceptable basifying or acidifying agents” to reach the same pH band. 2) What ingredients are mandatory to fall within independent claims 1-3?Based on the excerpted claim language: clobetasol propionate at 0.05 wt %, SLES at 2-25 wt %, cocoyl betaine at 1-15 wt %, ethanol (95%-96%) at the stated level (10 wt % per claims 2-3), and pH at 5.5-6.5 with the specified pH adjuster regime per claim. A qualifying polymer (polyquaternium 10 and/or cationic guar gum within the ranges/levels) is also required. 3) Which claim is most protective for competitors?Claim 3 is broader on polymer concentration and pH adjuster chemistry, so it typically covers more variants that keep the same active, surfactant ranges, ethanol level, and pH band. 4) Are the ratio limits optional?They are additional limitations in dependent claims 4-6. If a product does not meet those ratios, it may still potentially fall within claims 1-3 unless it also misses another independent limitation. 5) How do you most efficiently design around this patent?The most direct routes are changing at least one high-impact hard constraint: clobetasol propionate level (0.05 wt %), pH (outside 5.5-6.5), ethanol level/presence or strength, or dropping SLES/cocoyl betaine outside the stated ranges. Ratio shifts help only for formulations that otherwise remain inside claims 1-3. References[1] US Patent 8,066,975 (claim text as provided by user). More… ↓ |
Drugs Protected by US Patent 8,066,975
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,066,975
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| France | 98 07802 | Jun 19, 1998 |
International Family Members for US Patent 8,066,975
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 019321 | ⤷ Start Trial | |||
| Austria | 308960 | ⤷ Start Trial | |||
| Austria | 444054 | ⤷ Start Trial | |||
| Australia | 4151499 | ⤷ Start Trial | |||
| Australia | 753735 | ⤷ Start Trial | |||
| Brazil | 9911849 | ⤷ Start Trial | |||
| Canada | 2333427 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
